Brent Saunders (via AP Images)

Brent Saun­ders piv­ots from Al­ler­gan sale to a $460M SPAC, mak­ing him an overnight play­er in one of the hottest mon­ey-rais­ing gam­bits in biotech

It was on­ly a mat­ter of time be­fore Brent Saun­ders start­ed wheel­ing and deal­ing again. And what bet­ter ve­hi­cle to choose for his first se­ri­ous …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.